Persistent inflammatory markers existing with HIV-1 reservoirs in antiretroviral therapy treated HIV-1 individuals
Authors:
Abstract
No abstract availableKeywords
Funding Information
- Fundamental Research Funds for Central Universities of the Central South University (WK9110000166)
- Major Project of Philosophy and Social Science Research in Colleges and Universities of Jiangsu Province (AHWJ2022b057)
- Natural Science Foundation of Anhui Province (2208085QH257)
- Natural Science Foundation of Anhui Province (2208085MH260)
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China (2208085MH260)
- Ministry of Science and Technology of the People's Republic of China (202104j07020042)
- Ministry of Science and Technology of the People's Republic of China (2022e07020005)
- Anhui Provincial Key Research and Development Plan
This publication has 55 references indexed in Scilit:
- Aging-Related Comorbidity Burden Among Women and Men With or At-Risk for HIV in the US, 2008-2019JAMA Network Open, 2023
- TCR-independent CD137 (4-1BB) signaling promotes CD8+-exhausted T cell proliferation and terminal differentiationImmunity, 2023
- Upregulation of IFN-stimulated genes persists beyond the transitory broad immunologic changes of acute HIV-1 infectioniScience, 2023
- Size of HIV‐1 reservoir is associated with telomere shortening and immunosenescence in early‐treated European children with perinatally acquired HIV‐1Journal of the International AIDS Society, 2021
- Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016JAMA Network Open, 2020
- CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapyCancer Treatment Reviews, 2018
- Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trialThe Lancet Infectious Diseases, 2015
- CXCR3 Chemokine Receptor Enables Local CD8+ T Cell Migration for the Destruction of Virus-Infected CellsImmunity, 2015
- Antiretroviral therapy and management of HIV infectionThe Lancet, 2010
- IL-18: A TH1 -inducing, proinflammatory cytokine and new member of the IL-1 familyJournal of Allergy and Clinical Immunology, 1999